201 related articles for article (PubMed ID: 17653110)
21. 5-Hydroxytryptamine increases excitability of CA1 hippocampal pyramidal cells.
Beck SG
Synapse; 1992 Apr; 10(4):334-40. PubMed ID: 1585262
[TBL] [Abstract][Full Text] [Related]
22. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
[TBL] [Abstract][Full Text] [Related]
23. NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment.
Moyano S; Frechilla D; Del Río J
Psychopharmacology (Berl); 2004 May; 173(3-4):337-45. PubMed ID: 14985918
[TBL] [Abstract][Full Text] [Related]
24. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
Freezer A; Salem A; Irvine RJ
Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
[TBL] [Abstract][Full Text] [Related]
25. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
[TBL] [Abstract][Full Text] [Related]
26. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
Morley KC; Arnold JC; McGregor IS
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
[TBL] [Abstract][Full Text] [Related]
27. Endogenous serotonin facilitates hippocampal long-term potentiation at CA3/CA1 synapses.
Mlinar B; Stocca G; Corradetti R
J Neural Transm (Vienna); 2015 Feb; 122(2):177-85. PubMed ID: 24872079
[TBL] [Abstract][Full Text] [Related]
28. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Synapse; 2005 Dec; 58(4):229-35. PubMed ID: 16206181
[TBL] [Abstract][Full Text] [Related]
29. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
30. Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus.
Szabo ST; Blier P
Neuropsychopharmacology; 2001 Dec; 25(6):845-57. PubMed ID: 11750178
[TBL] [Abstract][Full Text] [Related]
31. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.
Meyer JS; Piper BJ; Vancollie VE
Ann N Y Acad Sci; 2008 Oct; 1139():151-63. PubMed ID: 18991859
[TBL] [Abstract][Full Text] [Related]
32. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
[TBL] [Abstract][Full Text] [Related]
33. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
Bankson MG; Cunningham KA
J Pharmacol Exp Ther; 2001 Jun; 297(3):846-52. PubMed ID: 11356903
[TBL] [Abstract][Full Text] [Related]
34. Treadmill exercise alters ecstasy- induced long- term potentiation disruption in the hippocampus of male rats.
Sajadi A; Amiri I; Gharebaghi A; Komaki A; Asadbegi M; Shahidi S; Mehdizadeh M; Soleimani Asl S
Metab Brain Dis; 2017 Oct; 32(5):1603-1607. PubMed ID: 28612273
[TBL] [Abstract][Full Text] [Related]
35. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
Kramer HK; Poblete JC; Azmitia EC
Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
[TBL] [Abstract][Full Text] [Related]
36. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
Shankaran M; Yamamoto BK; Gudelsky GA
Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
[TBL] [Abstract][Full Text] [Related]
37. A genetic deletion of the serotonin transporter differentially influences the behavioural effects of MDMA.
Pettie M; Oakly A; Harper DN; Ellenbroek BA
J Psychopharmacol; 2019 Mar; 33(3):355-363. PubMed ID: 30665313
[TBL] [Abstract][Full Text] [Related]
38. Influence of PCPA and MDMA (ecstasy) on physiology, development and behavior in Drosophila melanogaster.
Dasari S; Viele K; Turner AC; Cooper RL
Eur J Neurosci; 2007 Jul; 26(2):424-38. PubMed ID: 17650115
[TBL] [Abstract][Full Text] [Related]
39. MDMA induced dopamine release in vivo: role of endogenous serotonin.
Koch S; Galloway MP
J Neural Transm (Vienna); 1997; 104(2-3):135-46. PubMed ID: 9203077
[TBL] [Abstract][Full Text] [Related]
40. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.
Liechti ME; Saur MR; Gamma A; Hell D; Vollenweider FX
Neuropsychopharmacology; 2000 Oct; 23(4):396-404. PubMed ID: 10989266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
